CITY OF HOPE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 128133
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 11065
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 8331
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7852
 
  
 
C07K PEPTIDES 5284
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 4059
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 34172
 
  
 
C07D HETEROCYCLIC COMPOUNDS 25137
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 18222
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0360,910 CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLSDec 07, 15Dec 21, 17[A61K, C12N, C07K]
2017/0260,277 CD123-Specific Chimeric Antigen Receptor Redirected T Cells and Methods of Their UseMay 22, 17Sep 14, 17[C07K]
2017/0262,189 MEMORY MANAGEMENT SYSTEM AND METHODSSep 23, 15Sep 14, 17[G06F]
2017/0246,273 RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOFJul 17, 15Aug 31, 17[A61K, C12N, C07K]
2017/0224,733 Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous SystemFeb 06, 17Aug 10, 17[A61K]
2017/0209,543 Chimeric Immunoreceptor Useful in Treating Human CancersDec 21, 15Jul 27, 17[A61K, C07K]
2017/0198,265 ADENO-ASSOCIATED VIRUS VECTOR VARIANTS FOR HIGH EFFICIENCY GENOME EDITING AND METHODS THEREOFJan 23, 17Jul 13, 17[C12N, C07K]
2017/0135,752 COAPTIVE SURGICAL SEALING TOOLOct 21, 16May 18, 17[A61B]
2017/0122,938 NUCLEIC ACID-FUNCTIONALIZED NANOPARTICLESOct 31, 16May 04, 17[G01N]
2017/0037,058 ETP DERIVATIVESAug 19, 16Feb 09, 17[C07D]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914909 Costimulatory chimeric antigen receptor T cells targeting IL13Rα2May 27, 16Mar 13, 18[A61K, C12N, C07K]
9890396 Adeno-associated virus vector variants for high efficiency genome editing and methods thereofSep 23, 16Feb 13, 18[A61K, C12N, A01K, C07K]
9872730 Microwave coaptive surgical sealing toolSep 30, 16Jan 23, 18[A61B]
9873875 Methods and compositions for the specific inhibition of gene expression by double-stranded RNASep 08, 16Jan 23, 18[C07H, C12N]
9855233 -(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdGNov 07, 14Jan 02, 18[A61K, G01N, A61N]
9856273 ETP derivativesAug 19, 16Jan 02, 18[A61K, C07D]
9848942 Coaptive surgical sealing toolOct 21, 16Dec 26, 17[A61B]
9839696 Recombinant adeno-associated vectors for targeted treatmentMar 09, 17Dec 12, 17[A61K, C12N, C07K]
9834789 Recombinant adeno-associated vectors for targeted treatmentMar 21, 17Dec 05, 17[A61K, C12N, C07K]
9828342 Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereofFeb 25, 13Nov 28, 17[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0130,581 TARGETING DOMAIN AND RELATED SIGNAL ACTIVATED MOLECULAR DELIVERYAbandonedOct 13, 15May 12, 16[C12N]
2016/0068,517 5-BROMO-INDIRUBINSAbandonedSep 10, 15Mar 10, 16[A61K, C07D]
2015/0297,640 Method of Controlling Administration of Cancer AntigenAbandonedNov 17, 14Oct 22, 15[A61K]
2015/0259,288 5-BROMO-INDIRUBINSAbandonedMar 16, 15Sep 17, 15[C07D]
2014/0378,526 DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONSAbandonedJun 19, 14Dec 25, 14[C12Q, C12N]
2014/0030,727 LOSS OF 5-HYDROXYMETHYLCYTOSINE AS A BIOMARKER FOR CANCERAbandonedJan 22, 13Jan 30, 14[G01N]
2013/0317,316 CARBOHYDRATE MODELING METHODS, SYSTEMS, AND DEVICESAbandonedMay 28, 13Nov 28, 13[G06F]
2013/0309,172 CLEAVABLE FUNCTIONALIZED NANOPARTICLESAbandonedMay 06, 13Nov 21, 13[A61K]
2013/0183,667 METHODS FOR CANCER SCREENING IN LATIN AMERICAN/HISPANIC POPULATIONSAbandonedAug 13, 12Jul 18, 13[C12Q]
2013/0149,337 METHOD OF CONTROLLING ADMINISTRATION OF CANCER ANTIGENAbandonedSep 29, 11Jun 13, 13[A61K]
2013/0116,147 DNA METHYLATION BIOMARKERS FOR LUNG CANCERAbandonedJan 10, 13May 09, 13[C12Q]
2013/0017,540 IDENTIFICATION OF MUTATION TYPES ASSOCIATED WITH ACQUIRED RESISTANCE AND METHODS FOR USING SAMEAbandonedJun 07, 12Jan 17, 13[C12Q, G06F]
2012/0301,889 Method and reagents for identifying pluripotent stem cellsAbandonedMay 21, 12Nov 29, 12[C12Q, G01N, C07K]
2012/0238,022 INDUCIBLE SYSTEMS AND METHODS FOR CONTROLLING siRNA EXPRESSIONAbandonedMar 20, 12Sep 20, 12[C12N]
2012/0095,080 METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULESAbandonedDec 13, 11Apr 19, 12[A61K, C12P, C12N]
2011/0301,050 DNA HYPERMETHYLATION BRAIN CANCER MARKERSAbandonedMar 22, 11Dec 08, 11[C07H, C12Q, C40B]
2011/0301,224 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNAAbandonedJul 08, 11Dec 08, 11[A61K, C07H, C12N]
2011/0071,210 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASESAbandonedSep 10, 10Mar 24, 11[A61K, C07H, A61P]
2011/0065,908 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNAAbandonedNov 29, 10Mar 17, 11[C07H]
2010/0324,121 METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNAAbandonedAug 12, 10Dec 23, 10[A61K, C07H, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.